Pharmaceutical Supply – Guaifenesin Extended-Release Tablets

The contract specifies the supply and delivery of two boxes of Guaifenesin Extended-Release 600 mg tablets under the medical procurement standards of the Department of Defense. The items are intended to meet stringent regulatory and quality requirements mandated for military medical use, ensuring consistency, safety, and efficacy within the DoD healthcare system. This subcontract is administered by the Defense Logistics Agency and falls under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The contract was posted on July 20, 2026, and is linked to a specific award and delivery identification through DIBBS, indicating it is part of an active procurement cycle. While details such as the place of performance and point of contact are not provided, the contract's structure suggests it is a streamlined fulfillment effort supporting routine medical inventory needs across DoD facilities. Compliance with federal procurement protocols and adherence to pharmaceutical standards are central to executing this obligation.